These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8020047)

  • 1. [K-channel activators and cardioprotection].
    Specchia G; Marsico F; Laudisa ML
    Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-angina activity of potassium-channel activators].
    Chiariello M; Duilio C; Ambrosio G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
    Critz SD; Liu GS; Chujo M; Downey JM
    J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K(+)-channel openers protect the myocardium against ischemia-reperfusion injury.
    Popescu LM; Musat S; Trifan OC; Leabu M; Tigaret CM; Popescu M; Popescu A; Hinescu ME; Moraru II; Das DK
    Ann N Y Acad Sci; 1994 Jun; 723():398-400. PubMed ID: 8030895
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.
    Fryer RM; Hsu AK; Gross GJ
    J Mol Cell Cardiol; 2001 Apr; 33(4):831-4. PubMed ID: 11273735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P; Chiariello M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract]   [Full Text] [Related]  

  • 10. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C; Purcell H; Fox K
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial K(ATP) channel opener prevents ischemia-reperfusion injury in rat liver.
    Hai S; Takemura S; Minamiyama Y; Yamasaki K; Yamamoto S; Kodai S; Tanaka S; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):428-31. PubMed ID: 15808666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H; Fox K
    Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection.
    Fukuda H; Luo CS; Gu X; Guo L; Digerness SB; Li J; Pike MM
    J Mol Cell Cardiol; 2001 Mar; 33(3):545-60. PubMed ID: 11181022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 19. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
    Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
    Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers.
    Jayawant AM; Lawton JS; Hsia PW; Damiano RJ
    Circulation; 1997 Nov; 96(9 Suppl):II-240-6. PubMed ID: 9386105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.